Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Colic
Colic
24 registered clinical trials studyying Colic —
2 currently recruiting
.
Status
Trial
Sponsor
Phase
Recruiting
Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive
NCT07347743
Universitair Ziekenhuis Brussel
N/A
Not Yet Recruiting
The Effect of Cranial Osteopathy Intervention in Preterm Babies
NCT06967870
Abant Izzet Baysal University
N/A
Unknown
Probiotics Strains for Infant Colic
NCT05685030
Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude
Phase 2
Terminated
Human Milk Oligosaccharide (HMO) Supplementation in Colic Management
NCT05554991
Société des Produits Nestlé (SPN)
N/A
Completed
First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
NCT05052476
Astel Medica
N/A
Withdrawn
The Effect of Probiotics on Symptoms of Infantile Colic
NCT05198700
Lallemand Health Solutions
Phase 2
Completed
PRobiotics for EVEry Newborn Trial
NCT04537494
The Hospital for Sick Children
N/A
Unknown
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
NCT04983069
University Hospital, Montpellier
—
Terminated
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
NCT02586558
McMaster University
N/A
Completed
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
NCT02865564
University Medical Centre Ljubljana
N/A
Unknown
Prevention of Colic With the Probiotic Lactobacillus Reuteri
NCT02577133
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Phase 2 / Phase 3
Unknown
Treatment of Suspected Cholelithiasis With Nitroglycerin
NCT01715220
United States Naval Medical Center, San Diego
Phase 2
Completed
Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected
NCT01997593
Ping Yang
Phase 2
Completed
Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic
NCT01849991
The University of Texas Health Science Center, Houston
Phase 1
Completed
Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic
NCT01541046
The Hospital for Sick Children
Phase 2
Completed
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
NCT01279265
The University of Texas Health Science Center, Houston
N/A
Completed
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
NCT01532518
Menarini Group
Phase 2
Completed
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
NCT00922727
The University of Texas Health Science Center, Houston
Phase 1
Unknown
Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri
NCT01067027
Children's Investigational Research Program, LLC
Phase 4
Completed
Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants
NCT00929292
Sodilac
Phase 3
Completed
Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional A
NCT02242292
Boehringer Ingelheim
Phase 2
Completed
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
NCT00177086
University of Minnesota
Phase 3
Completed
An Intervention to Decrease Infant Crying
NCT00796523
Riverside Methodist Hospital
N/A
Terminated
Parecoxib in Renal Colic
NCT00139646
Pfizer
Phase 3